TissueLabs is a Swiss biopharma and biotechnology startup founded in 2019. With the slogan "The platform for creating organs and tissues in the lab," this innovative company has garnered significant attention within the industry. In its most recent funding round on 22 March 2024, TissueLabs secured an impressive $800.00K in a Pre Seed Round, attracting investments from MIT Alumni Angels and Mergus Ventures.
TissueLabs
The platform for creating organs and tissues in the lab.
Founded 2019
Switzerland
14 employees
Pre Seed
Total: $5.42M
Biopharma, Biotechnology +3
Switzerland
14 employees
Pre Seed
Total: $5.42M
Biopharma, Biotechnology +3
General Information
Get notified when TissueLabs moves
Funding, new markets, leadership changes, hiring surges — one e-mail, only when something happens.
Track TissueLabs
Get real-time alerts for funding, hiring, news, and 40+ signal types.
See how it worksDiscover More
Switzerland Market
Biopharma
About TissueLabs
Taxonomy: tissue engineering, regenerative medicine, biomaterials, lab-grown organs, research equipment, biomaterials services, regenerative medicine services, innovation, drug discovery, organ development, biofabrication, cutting-edge technology
Funding Rounds & Investors (10)
View All| Funding Stage | Amount | Investors | Lead Investors | Date |
|---|---|---|---|---|
| Pre Seed Round | •••••• | 2 |
|
22 Mar 2024 |
| Pre Seed Round | •••••• | 1 |
|
05 Jan 2023 |
| Grant | •••••• | 1 | •••• •••• | 01 Feb 2022 |
| Grant | •••••• | 1 |
|
12 Sep 2021 |
| Non Equity Assistance | •••••• | 1 | •••• •••• | 17 May 2021 |
TissueLabs Alternatives & Competitors
TissueLabs vs
TissueLabs vs
Dimension Inx
United States
Biomaterials, reimagined.
Series A
28 employees
Biotechnology, Health and Wellness
TissueLabs vs
4D Biomaterials
United Kingdom
4Degra® 3D printing biomaterials - helping people heal. Regenerative, resorbable and customisable.
Seed
9 employees
Biotechnology, Health Care
FAQ About TissueLabs
The platform for creating organs and tissues in the lab.
TissueLabs was founded in 2019.
TissueLabs is headquartered in Switzerland.
TissueLabs operates in the following industries: Biopharma, Biotechnology, Health and Wellness, Life Sciences, 3D Printing.
TissueLabs has approximately 14 employees.
TissueLabs has completed 10 funding rounds, raising a total of $5.42M. The latest funding stage is Pre Seed.
Top alternatives and competitors to TissueLabs include Cells for Cells, Dimension Inx, 4D Biomaterials, Optics11 Life, Vetherapy® - Veterinary Regenerative Medicine. These companies operate in related industries and serve comparable markets. You can compare them side by side on Bounce Watch.
TissueLabs and Cells for Cells are both companies in similar industries. Compare their funding, team size, growth signals, and market position on Bounce Watch to see which one fits your needs.
Don't just browse. Track.
Signal Tracker monitors TissueLabs and millions of companies for funding rounds, hiring surges, product changes, and 40+ signal types — so you never miss an opportunity.